These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21123732)

  • 1. Increased matriptase zymogen activation in inflammatory skin disorders.
    Chen CJ; Wu BY; Tsao PI; Chen CY; Wu MH; Chan YL; Lee HS; Johnson MD; Eckert RL; Chen YW; Chou F; Wang JK; Lin CY
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C406-15. PubMed ID: 21123732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation.
    Chen YW; Wang JK; Chou FP; Chen CY; Rorke EA; Chen LM; Chai KX; Eckert RL; Johnson MD; Lin CY
    J Biol Chem; 2010 Oct; 285(41):31755-62. PubMed ID: 20696767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin.
    Lee SP; Kao CY; Chang SC; Chiu YL; Chen YJ; Chen MG; Chang CC; Lin YW; Chiang CP; Wang JK; Lin CY; Johnson MD
    PLoS One; 2018; 13(2):e0192632. PubMed ID: 29438412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
    Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
    PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deletion of HAI-1 increases prostasin proteolysis but decreases matriptase proteolysis in human keratinocytes.
    Lu DD; Gu Y; Li SA; Barndt RJ; Huang SM; Wang JK; Su HC; Johnson MD; Lin CY
    Hum Cell; 2021 May; 34(3):771-784. PubMed ID: 33486722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased matriptase zymogen activation by UV irradiation protects keratinocyte from cell death.
    Chen CY; Chen CJ; Lai CH; Wu BY; Lee SP; Johnson MD; Lin CY; Wang JK
    J Dermatol Sci; 2016 Jul; 83(1):34-44. PubMed ID: 26996264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
    Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
    Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of matriptase and proteinase-activated receptor-2 in nonmelanoma skin cancer.
    Bocheva G; Rattenholl A; Kempkes C; Goerge T; Lin CY; D'Andrea MR; Ständer S; Steinhoff M
    J Invest Dermatol; 2009 Jul; 129(7):1816-23. PubMed ID: 19242518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matriptase and prostasin proteolytic activities are differentially regulated in normal and wounded skin.
    Chang SC; Chiang CP; Lai CH; Du PA; Hung YS; Chen YH; Yang HY; Fang HY; Lee SP; Tang HJ; Wang JK; Johnson MD; Lin CY
    Hum Cell; 2020 Oct; 33(4):990-1005. PubMed ID: 32617892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.
    Lee MS; Kiyomiya K; Benaud C; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Apr; 288(4):C932-41. PubMed ID: 15590895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes.
    Chen YW; Xu Z; Baksh AN; Wang JK; Chen CY; Swanson R; Olson ST; Kataoka H; Johnson MD; Lin CY
    PLoS One; 2013; 8(5):e62826. PubMed ID: 23675430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1.
    Xu H; Xu Z; Tseng IC; Chou FP; Chen YW; Wang JK; Johnson MD; Kataoka H; Lin CY
    Am J Physiol Cell Physiol; 2012 Jan; 302(2):C453-62. PubMed ID: 22031598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
    Domoto T; Takino T; Guo L; Sato H
    Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor.
    Benaud C; Dickson RB; Lin CY
    Eur J Biochem; 2001 Mar; 268(5):1439-47. PubMed ID: 11231297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
    Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
    J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matriptase expression and zymogen activation in human pilosebaceous unit.
    Wu BY; Lee SP; Hsiao HC; Chiu H; Chen CY; Yeo YH; Lee HS; Chen YW; Kaul M; Kataoka H; Johnson MD; Wang JK; Lin CY
    J Histochem Cytochem; 2014 Jan; 62(1):50-9. PubMed ID: 24004857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease.
    Oberst MD; Chen LY; Kiyomiya K; Williams CA; Lee MS; Johnson MD; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Aug; 289(2):C462-70. PubMed ID: 15800053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.